Dr. Reddys Laboratories announced the launch of Dr. Reddys Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar? (sorafenib) Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration (USFDA). Dr. Reddys Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
